11:30 EDT Protagonist Therapeutics (PTGX) resumes, up 28% after report of J&J takeover talks
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PTGX:
- Protagonist Therapeutics trading resumes
- J&J in talks to buy Protagonist Therapeutics, WSJ reports
- Protagonist Therapeutics jumps 9%, halted after WSJ report on J&J takeover talks
- Johnson & Johnson in talks to buy Protagonist Therapeutics, WSJ reports
- Protagonist Therapeutics trading halted, volatility trading pause